Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41003 in inflammatory tinea pedis
NCT01096472Phase 2Completed
- Sponsor
- Almirall
- Start
- Feb 2010
- Primary completion
- Jun 2010
- Modality
- Lipid-based Nanoparticles, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of octenidine, prednicarbate in tinea pedis, sponsored by Almirall. Started Feb 2010; status: completed.
02
Drugs
octenidineprednicarbate
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT01096472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096472.